EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mesoporous Silica Nanoplatforms: From Controllable Synthesis to Versatile Biomedical Applications

Yu Gao, Yinuo Liu, Dugang Chen iD, Wenbo Wu iD

Advanced Healthcare Materials · 30.10.2026

DOI: 10.1002/adhm.71928 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 30.10.2026. Verfasst von Yu Gao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Green Chemical Process of Ministry of Education, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan…. Die Arbeit nennt 306 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Graduate Innovative Fund of Wuhan Institute of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing global burden of severe diseases, such as cancers, cardiovascular and neurodegenerative disorders, highlights the urgent need for advanced diagnostic and therapeutic agents. Although techniques like computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and chemotherapy show promise, their effectiveness is frequently constrained by the inherent drawbacks of conventional agents, such as poor solubility, low stability, and lack of targeting ability, as well as physiological barriers like the blood‐brain barrier (BBB), which limit bioavailability and induce systemic toxicity. Mesoporous silica nanoparticles (MSNs) have emerged as promising platforms to overcome these challenges, offering high surface area, tunable pore size, and facile surface functionalization for efficient cargo loading. Therefore, in this work, the recent advances in the synthesis, structural control, and functional design of MSNs‐based composites are systematically reviewed, with a focus on their biomedical applications in diagnosis (e.g., fluorescence imaging (FLI)/MRI/PET), therapy (e.g., chemo‐, dynamic, thermal, and gas therapy), and tissue engineering. Key strategies for performance optimization and structure‐property relationships are discussed in depth. Finally, we delineate prevailing challenges and future directions for the clinical translation of MSNs‐based nanomaterials, providing an integrated perspective to guide their rational design and biomedical implementation.

Schlagwörter

Stichwörter der Autor:innen

bioimagingdrug deliverymesoporous silica nanoparticlesnanocarriertherapy

Autor:innen und Institutionen

  • Key Laboratory for Green Chemical Process of Ministry of Education, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, P. R. China.
  • Department of Chemistry, Institute of Molecular Aggregation Science, Tianjin University, Tianjin, P. R. China.
  • State Key Laboratory of Advanced Materials For Intelligent Sensing, Tianjin University, Tianjin, P. R. China.
  • The International Joint Institute of Tianjin University, Fuzhou, Tianjin University, Tianjin, P. R. China.

ORCID-Profile: Dugang Chen, Wenbo Wu

Förderung

  • National Natural Science Foundation of China
  • Graduate Innovative Fund of Wuhan Institute of Technology

Zitieren

APA

Gao, Y., Liu, Y., Chen, D., & Wu, W. (2026). Mesoporous Silica Nanoplatforms: From Controllable Synthesis to Versatile Biomedical Applications. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71928

Vancouver

Gao Y, Liu Y, Chen D, Wu W. Mesoporous Silica Nanoplatforms: From Controllable Synthesis to Versatile Biomedical Applications. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71928

BibTeX
@article{Gao2026,
  author = {Gao, Yu and Liu, Yinuo and Chen, Dugang and Wu, Wenbo},
  title = {Mesoporous Silica Nanoplatforms: From Controllable Synthesis to Versatile Biomedical Applications},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71928}
}
Kostenlos starten →